CLL PHARMA
5Patents
3Active
5Granted
34Portfolio score
Filing activity: Jul 25, 1996 → Jul 11, 2011 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5827536A | Pharmaceutical dosage formulations of fenofibrate and their applications | Human Necessities | 73 | Expired |
| US6669957B1 | Galenic formulations fast disintegrating in the mouth and method for preparing same | Human Necessities | 22 | Expired |
| US9427455B2 | Use of the pat nanopeptide in the treatment of autoimmune diseases | Human Necessities | 0 | Active |
| US9029390B2 | Oral composition containing an antiplatelet agent of the thienopyridine family in the form of free base | Human Necessities | 0 | Active |
| US9192654B2 | Use of the PAT nanopeptide in treating and preventing neurodegenerative diseases | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.